Program
Salk T32 Cancer Symposium 2021 Program
*All times listed are Pacific Standard Time
Zoom meeting link: https://salk-edu.zoom.us/j/85719807271?pwd=dXo1K25peCtTcjd5U0grUkxxMUNaQT09
9:30 a.m. – 9:35 a.m. | Welcome and Introduction, Susan Kaech, Salk |
9:35 a.m.– 10:10 a.m. | Cosimo Commisso, SBP “Mechanisms of Metabolic Stress Tolerance in Ras-mutant Tumors” |
10:10 a.m. – 10:45 a.m. | Heather Christofk, UCLA “Targeting Cancer Asparagine Dependence” |
10:45 a.m. – 10:55 a.m. | Break |
10:55 a.m. – 11:05 a.m. | Speed talks Round 1 |
Na Li, UCSD “ALKBH5 Regulates anti–PD-1 Therapy Response by Modulating Lactate and Suppressive Immune Cell Accumulation in Tumor Microenvironment” | |
Cristina Andreani, University of Cincinnati “FASN Inhibition and Ferroptosis in Mutant KRAS Lung Cancer” | |
Dilru Silva, University of Utah “Investigating the Mechanisms Governing CDK4/6 Regulated Autophagy in Pancreatic Cancer” | |
Thekla Cordes, UCSD “Mitochondrial pyruvate metabolism and alanine oxidation influence anchorage-independent cancer cell growth” | |
11:05 a.m. – 11:18 a.m. | Gabriela Fort, University of Utah “Elucidating mechanisms of resistance to arginine deprivation in MYC-driven small cell lung cancer (SCLC)” |
11:18 a.m. – 11:30 a.m. | Meredith Frie, Salk “Mutant Zap70 improves T cell activity against tumor neoantigens” |
11:30 a.m. – 12:05 p.m. | Navdeep Chandel, Northwestern “Mitochondria and Cancer” |
12:05 p.m.– 12:45 p.m. | Lunch |
12:45 p.m. – 1:20 p.m. | Donita Brady, University of Pennsylvania “Copper Conducted Kinase Signal Transduction: Mechanisms and Vulnerabilities in Cancer” |
1:20 p.m. – 1:55 p.m. | Joshua Rabinowitz, Princeton “Energy Sources in Tissues and Tumors” |
1:55 p.m. – 2:05 p.m. | Break |
2:05 p.m. – 2:15 p.m. | Speed talks Round 2 |
Ziyan “Zoe” Xu, Salk “Metabolic and Functional Regulation of Tumor-Associated Macrophages” | |
Amin Sobh, University of Florida “Adenylate Kinase 2 is a Selective Dependency in NSD2-high Multiple Myeloma” | |
Caterina Bartolacci, University of Cincinnati “FASN imposes a targetable metabolic dependency on mutant KRAS lung cancer” | |
Shruti Bhargava, UCSD “Patient-Derived Human Succinate Dehydrogenase-Mutant Gastrointestinal Stromal Tumors Models Identify Novel Drug Vulnerabilities” | |
2:15 p.m. – 2:27 p.m. | Archna Ravi, SBP “PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay” |
2:27 p.m. – 2:40 p.m. | Michael Trogdon, Salk “Systems modeling of oncogenic mutations in uveal melanoma” |
2:40 p.m. – 3:15 p.m. | Dafna Bar-Sagi, NYU “Protein Scavenging and Tumor Fitness: A Dynamic Partnership” |
3:15 p.m. – 3:20 p.m. | Closing, Reuben Shaw, Salk |